Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of Diffuse Large B-Cell Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview ... Read More
-
Preclinical CRO Market Forecast till 2030
... therapies increases, pharmaceutical and biotech companies are allocating larger budgets for R&D to accelerate the drug development process. This includes outsourcing preclinical research activities to CROs, which offer specialized services and expertise in conducting preclinical ... Read More
-
IgA Nephropathy (Berger's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on IgA Nephropathy (Berger's Disease). Report includes an overview ... Read More
-
Clinical Trials Market - By Phases (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology) & Forecast, 2023 - 2032
... & Forecast, 2023 - 2032 Global Clinical Trials Market size is anticipated to record an appreciable valuation by 2032, owing to the increasing prospects for performing clinical trials in the Asia Pacific. The consistent rise ... Read More
-
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1 billion prevalent cases of AC in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AC. The innovator marketed drugs space for AC mainly consists of dual-acting antihistamines and mast cell inhibitors. ... Read More
-
Membranous Nephropathy
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 0.49 million diagnosed prevalent cases of IPF in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for IPF. Currently, there are two leading marketed drugs for the treatment of IPF, with Roche ... Read More
-
Virtual Clinical Trials Market, By Study Type (Interventional and Others), By Phases (Late Stage and Early Stage), By Company Size (Small- & Mid-sized and Large-sized), By Therapeutic Area (Oncology, Rare & Genetic Diseases, CNS, Immunology, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Virtual clinical trials is a relatively new method of ... Read More
-
Clinical Reference Laboratory Market by Type (Standalone, Clinical-based, Hospital-based), By Application (Clinical Trials, Laboratory Medicine) By Region – Global Market Insights 2023 to 2033
... by Fact.MR on the Clinical Reference Laboratory market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital ... Read More
-
Global Cardiovascular Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Observational, Expanded Access), by Indication (Acute Coronary Syndrome, Coronary Artery Disease, Ischemic Heart Disease, Pulmonary Arterial Hypertension, Stroke/Cerebrovascular Disease, Cardiac Arrhythmias, Heart Failure, Others) and Regional Analysis, 2022-2029
... Heart Disease, Pulmonary Arterial Hypertension, Stroke/Cerebrovascular Disease, Cardiac Arrhythmias, Heart Failure, Others) and Regional Analysis, 2022-2029 Global Cardiovascular Clinical Trials Market is valued at approximately USD XX billion in 2021 and is anticipated to grow ... Read More
-
Global Neurology Clinical Trial Market Growth (Status and Outlook) 2023-2029
... grow at a CAGR of % from 2023 to 2029. United States market for Neurology Clinical Trial is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of ... Read More
-
Global Mental Health Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Observational, Expanded Access) by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Government Agencies, Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029
... Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029 Global Mental Health Clinical Trials Market is valued at approximately USD XX billion in 2021 and ... Read More
-
2023 Global: Clinical Trial Management System Market - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
2023 Global: Clinical Workflow Solutions Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Clinical Trials Matching Software - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Electronic Clinical Outcome Assessment Solutions - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... manufacturing techniques and processes are projected to help the CMO market grow. CMOs are expected to improve the efficiency of their manufacturing processes, minimizing waste and lowering costs, owing to new operational strategies, such as ... Read More
-
Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... of 5.05% over the forecast period. The COVID-19 pandemic tremendously impacted the market for clinical trials, as there has been a rising focus on developing new therapeutics or vaccines to treat the disease. Also, COVID-19 ... Read More
-
Future of Pharma - Looking Ahead to 2023
... of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors. Scope This 58-page ... Read More
-
Viral Vector Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... CAGR of 27.36% over the forecast period. The COVID-19 pandemic had underlined the importance of vaccine development for the global population, and it has had a positive impact on the growth of the viral vector ... Read More
-
Global Clinical Trial Imaging Platform Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Clinical Trial Imaging Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Intelligent Clinical Trials Market Growth (Status and Outlook) 2023-2029
... grow at a CAGR of % from 2023 to 2029. United States market for Intelligent Clinical Trials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of ... Read More
-
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
... market including disease overview, epidemiology, disease management, competitive assessment, unmet needs, R&D strategies, current and future players, and market outlook. Multiple sclerosis (MS) is an autoimmune disease principally affecting the central nervous system. It causes ... Read More
-
In Silico Clinical Trials Market: Current Analysis and Forecast (2022-2028)
... These simulations can be used to assess the safety and efficacy of drugs, medical devices, and other treatments before they are tested in real-world trials. The market of in silico clinical trials is increasing mainly ... Read More
-
Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
... diseases that cause intestinal inflammation: Crohn's disease (CD) and Ulcerative Colitis (UC). In Ulcerative Colitis (UC), chronic inflammation affects the colon (also known as the large intestine). Initially, Ulcerative Colitis (UC) usually manifests in the ... Read More
Research Assistance
